Home › Neuroendocrine Tumors › New York › New York City
Neuroendocrine Tumors clinical trials in New York City, NY
6 studies for Neuroendocrine Tumors are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Icahan School of Medicine at Mount Sinai, New York
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
- Investigative Site, New York
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 2 more
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, New York
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- Columbus, OH7 studies
- Chicago, IL7 studies
- St. Louis, MO7 studies
- Salt Lake City, UT7 studies
- Detroit, MI7 studies
- Cleveland, OH7 studies
- Dallas, TX6 studies
- Miami, FL6 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.